Search Results

There are 12318 results for: content related to: Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin

  1. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950

  2. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin

    Journal of Viral Hepatitis

    Volume 14, Issue 6, June 2007, Pages: 396–403, Y. Asahina, N. Izumi, N. Umeda, T. Hosokawa, K. Ueda, F. Doi, K. Tsuchiya, H. Nakanishi, K. Matsunaga, T. Kitamura, M. Kurosaki, M. Uchihara, M. Higaki and S. Miyake

    Version of Record online : 25 AUG 2006, DOI: 10.1111/j.1365-2893.2006.00803.x

  3. Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen

    Hepatology

    Volume 63, Issue 6, June 2016, Pages: 1809–1816, Christophe Hézode, Stéphane Chevaliez, Giovanna Scoazec, Alexandre Soulier, Anne Varaut, Magali Bouvier-Alias, Isaac Ruiz, Françoise Roudot-Thoraval, Ariane Mallat, Cyrille Féray and Jean-Michel Pawlotsky

    Version of Record online : 10 MAR 2016, DOI: 10.1002/hep.28491

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  5. You have free access to this content
    Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1013–1023, Jean-Michel Pawlotsky, Robert Flisiak, Shiv K. Sarin, Jens Rasenack, Teerha Piratvisuth, Wan-Long Chuang, Cheng-Yuan Peng, Graham R. Foster, Samir Shah, Heiner Wedemeyer, Christophe Hézode, Wei Zhang, Kelly A. Wong, Bin Li, Claudio Avila, Nikolai V. Naoumov and on behalf of the VITAL-1 study team

    Version of Record online : 10 AUG 2015, DOI: 10.1002/hep.27960

  6. You have free access to this content
    Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1512–1522, Willem Pieter Brouwer, Qing Xie, Milan J. Sonneveld, Ningping Zhang, Qin Zhang, Fehmi Tabak, Adrian Streinu-Cercel, Ji-Yao Wang, Ramazan Idilman, Hendrik W. Reesink, Mircea Diculescu, Krzysztof Simon, Mihai Voiculescu, Meral Akdogan, Wlodzimierz Mazur, Jurrien G.P. Reijnders, Elke Verhey, Bettina E. Hansen, Harry L.A. Janssen and for the ARES Study Group

    Version of Record online : 27 FEB 2015, DOI: 10.1002/hep.27586

  7. Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 17, Issue 6, June 2010, Pages: 410–418, S. S. Tan, M. R. Abu Hassan, A. Abdullah, B. P. Ooi, T. Korompis and M. I. Merican

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1365-2893.2009.01191.x

  8. You have free access to this content
    AASLD guidelines for treatment of chronic hepatitis B

    Hepatology

    Volume 63, Issue 1, January 2016, Pages: 261–283, Norah A. Terrault, Natalie H. Bzowej, Kyong-Mi Chang, Jessica P. Hwang, Maureen M. Jonas and M. Hassan Murad

    Version of Record online : 13 NOV 2015, DOI: 10.1002/hep.28156

  9. You have free access to this content
    How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries

    Hepatology

    Volume 62, Issue 1, July 2015, Pages: 31–39, Dorothée Obach, Yazdan Yazdanpanah, Gamal Esmat, Anchalee Avihingsanon, Sahar Dewedar, Nicolas Durier, Alain Attia, Wagida A. Anwar, Anthony Cousien, Pisit Tangkijvanich, Serge Paul Eholié, Wahid Doss, Aya Mostafa, Arnaud Fontanet, Mostafa K. Mohamed and Sylvie Deuffic-Burban

    Version of Record online : 27 FEB 2015, DOI: 10.1002/hep.27691

  10. You have free access to this content
    Development and validation of a “capture-fusion” model to study drug sensitivity of patient-derived hepatitis C

    Hepatology

    Volume 61, Issue 4, April 2015, Pages: 1192–1204, Morven E. Cunningham, Alia Javaid, Jenny Waters, Joseph Davidson-Wright, Joshua L.C. Wong, Meleri Jones and Graham R. Foster

    Version of Record online : 13 FEB 2015, DOI: 10.1002/hep.27570

  11. You have free access to this content
    The global burden of liver disease: The major impact of China

    Hepatology

    Volume 60, Issue 6, December 2014, Pages: 2099–2108, Fu-Sheng Wang, Jian-Gao Fan, Zheng Zhang, Bin Gao and Hong-Yang Wang

    Version of Record online : 29 OCT 2014, DOI: 10.1002/hep.27406

  12. You have free access to this content
    Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1004–1012, Bashar A. Aqel, Surakit Pungpapong, Michael Leise, K. Tuesday Werner, Amy E. Chervenak, Kymberly D. Watt, Jennifer L. Murphy, Kristen Ryland, Andrew P. Keaveny, Ryan McLemore and Hugo E. Vargas

    Version of Record online : 7 AUG 2015, DOI: 10.1002/hep.27937

  13. You have free access to this content
    Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1471–1478, Zobair M. Younossi, Yushan Jiang, Nathaniel J. Smith, Maria Stepanova and Rachel Beckerman

    Version of Record online : 23 MAR 2015, DOI: 10.1002/hep.27757

  14. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  15. You have free access to this content
    Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1485–1494, Xavier Forns, Michael Charlton, Jill Denning, John G. McHutchison, William T. Symonds, Diana Brainard, Theo Brandt-Sarif, Paul Chang, Valerie Kivett, Lluís Castells, Martín Prieto, Robert J. Fontana, Thomas F. Baumert, Audrey Coilly, Maria Carlota Londoño and François Habersetzer

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27681

  16. Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 7pt1, July 2008, Pages: 1094–1104, Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Akihide Masumoto, Toshihiro Maruyama, Makoto Nakamuta, Munechika Enjoji, Koichi Azuma, Junya Shimono, Hironori Sakai, Shinji Shimoda, Jun Hayashi and Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 3 FEB 2008, DOI: 10.1111/j.1440-1746.2008.05319.x

  17. You have full text access to this OnlineOpen article
    Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C

    Hepatology

    Volume 60, Issue 3, September 2014, Pages: 832–843, Emmanuel A. Tsochatzis, Catriona Crossan, Louise Longworth, Kurinchi Gurusamy, Manolo Rodriguez-Peralvarez, Konstantinos Mantzoukis, Julia O'Brien, Evangelos Thalassinos, Vassilios Papastergiou, Anna Noel-Storr, Brian Davidson and Andrew K. Burroughs

    Version of Record online : 29 JUL 2014, DOI: 10.1002/hep.27296

  18. Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1137–1144, Hideyuki Tamai, Naoki Shingaki, Tatsuya Shiraki, Hiroshi Tukuda, Yoshiyuki Mori, Kosaku Moribata, Shotaro Enomoto, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Kimihiko Yanaoka, Masashi Oka and Masao Ichinose

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00879.x

  19. You have free access to this content
    Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study

    Hepatology

    Volume 58, Issue 6, December 2013, Pages: 1918–1929, Michael W. Fried, Maria Buti, Gregory J. Dore, Robert Flisiak, Peter Ferenci, Ira Jacobson, Patrick Marcellin, Michael Manns, Igor Nikitin, Fred Poordad, Morris Sherman, Stefan Zeuzem, Jane Scott, Leen Gilles, Oliver Lenz, Monika Peeters, Vanitha Sekar, Goedele De Smedt and Maria Beumont-Mauviel

    Version of Record online : 11 OCT 2013, DOI: 10.1002/hep.26641

  20. You have free access to this content
    Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes

    Hepatology

    Volume 59, Issue 3, March 2014, Pages: 828–838, Masao Honda, Takayoshi Shirasaki, Tetsuro Shimakami, Akito Sakai, Rika Horii, Kuniaki Arai, Tatsuya Yamashita, Yoshio Sakai, Taro Yamashita, Hikari Okada, Kazuhisa Murai, Mikiko Nakamura, Eishiro Mizukoshi and Shuichi Kaneko

    Version of Record online : 27 JAN 2014, DOI: 10.1002/hep.26788